Evidence map›Paper›PMID 40444744›Full record

ArticleACS nano2025

Glucose-Fueled Gated Nanomotors: Enhancing

Andrea Escudero, Francisco J Hicke, Elena Lucena-Sánchez, Sandra Pradana-López, Juan José Esteve-Moreno, Víctor Sanz-Álvarez, Iris Garrido-Cano, Sandra Torres-Ruiz, Juan Miguel Cejalvo, Alba García-Fernández and 2 more

Abstract read
In one paragraph

Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrea EscuderoInstituto Interuniversitario de Investigación de Reconocimiento Molecular yDesarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Camino de Vera, s/n., 46022 València, Spain.
Francisco J HickeInstituto Interuniversitario de Investigación de Reconocimiento Molecular yDesarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Camino de Vera, s/n., 46022 València, Spain.
Elena Lucena-SánchezInstituto Interuniversitario de Investigación de Reconocimiento Molecular yDesarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Camino de Vera, s/n., 46022 València, Spain.
Sandra Pradana-LópezInstituto Interuniversitario de Investigación de Reconocimiento Molecular yDesarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Camino de Vera, s/n., 46022 València, Spain.
Juan José Esteve-MorenoInstituto Interuniversitario de Investigación de Reconocimiento Molecular yDesarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Camino de Vera, s/n., 46022 València, Spain.
Víctor Sanz-ÁlvarezInstituto Interuniversitario de Investigación de Reconocimiento Molecular yDesarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Camino de Vera, s/n., 46022 València, Spain.
Iris Garrido-CanoInstituto Interuniversitario de Investigación de Reconocimiento Molecular yDesarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Camino de Vera, s/n., 46022 València, Spain.
Sandra Torres-RuizBiomedical Research Institute INCLIVA, Carrer de Menéndez y Pelayo,4, 46010 Valencia, Spain.
Juan Miguel CejalvoBiomedical Research Institute INCLIVA, Carrer de Menéndez y Pelayo,4, 46010 Valencia, Spain.
Alba García-FernándezInstituto Interuniversitario de Investigación de Reconocimiento Molecular yDesarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Camino de Vera, s/n., 46022 València, Spain.
Paula DíezInstituto Interuniversitario de Investigación de Reconocimiento Molecular yDesarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Camino de Vera, s/n., 46022 València, Spain.
Ramón Martínez-MáñezInstituto Interuniversitario de Investigación de Reconocimiento Molecular yDesarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Camino de Vera, s/n., 46022 València, Spain.ORCID 0000-0001-5873-9674

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioinspired nano/micromotors with drug delivery capabilities are emerging tools with the promising potential to treat numerous diseases. However, some major challenges must be overcome before reaching real biomedical applications. Above all, it is necessary to design engines that employ biocompatible and bioavailable fuels to induce efficient propulsion in biological environments. In addition, ideal nanomotors should also be capable of delivering the cargo on-command using selected stimuli. To tackle these challenges, we herein present the design and evaluation (both

Indexed as

Antineoplastic AgentsDoxorubicinGlucoseNanoparticlesNeoplasmsAnimalsCell Line, TumorDrug CarriersDrug Delivery SystemsGlucose OxidaseHumansMicePlatinumSilicon DioxideAntineoplastic AgentsDoxorubicinDrug CarriersGlucoseGlucose OxidasePlatinumSilicon Dioxideantitumor therapycontrolled-drug deliveryglucosenanomotorsplatinum-mesoporous silica nanoparticles

Identifiers

PMID40444744
PMCPMC12164516

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.